• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物利用与治疗干预项目:能实现自给自足的药学服务。

Drug utilization & therapeutic intervention programs: pharmacy services that pay for themselves.

作者信息

Condron J H, Mann J L

机构信息

Kitchener-Waterloo Hospital, Kitchener, Ontario.

出版信息

Can J Hosp Pharm. 1994 Oct;47(5):203-8.

PMID:10137698
Abstract

This mailed survey was a follow-up to a 1989 study to assess the status of pharmacy-directed, drug-related, patient care programs in response to the Pharmaceutical Inquiry of Ontario (Lowy Inquiry). A specific focus on Therapeutic Interventions and Drug Utilization Review/Evaluation Programs was adopted because the earlier study indicated a significant "financial return" for pharmacist time spent on these initiatives. A response rate of 62.2% (89 out of 143 hospitals) was achieved compared with an 80% response rate in 1989. Therapeutic interventions were performed by 97.7% of hospitals which identified an average of 184 therapeutic interventions per month and an 84.3% acceptance rate by prescriber. Based on data from 53 hospitals, an average of 29 minutes was taken on each intervention and financial data from 10 hospitals showed cost savings/avoidance of $49.34 per intervention. Drug Utilization program data was available from 45% of hospitals and specific financial data was provided by 29.2% of institutions. Cost savings/avoidance data demonstrated a return of $29.99 for every dollar invested in pharmacist time performing these activities. Collectively, both programs were recognized for their value in optimizing pharmacotherapy, improving patient outcomes as well as demonstrating a financial return to the institution. Despite the recessionary times, these programs are easily justified since they more than pay their own way.

摘要

这项邮寄调查是对1989年一项研究的后续跟进,该研究旨在评估针对安大略省药学调查(洛维调查)的由药学指导的、与药物相关的患者护理项目的现状。由于早期研究表明药剂师在这些项目上花费的时间有显著的“财务回报”,因此特别关注治疗干预和药物利用审查/评估项目。此次调查的回复率为62.2%(143家医院中的89家),而1989年的回复率为80%。97.7%的医院开展了治疗干预,平均每月确定184次治疗干预,处方医生的接受率为84.3%。根据53家医院的数据,每次干预平均耗时29分钟,10家医院的财务数据显示每次干预节省/避免成本49.34美元。45%的医院提供了药物利用项目数据,29.2%的机构提供了具体财务数据。成本节省/避免数据表明,在药剂师开展这些活动上每投入1美元可获得29.99美元的回报。总体而言,这两个项目在优化药物治疗、改善患者治疗效果以及为机构带来财务回报方面的价值得到了认可。尽管处于经济衰退时期,但这些项目很容易得到合理的解释,因为它们的收益超过了成本。

相似文献

1
Drug utilization & therapeutic intervention programs: pharmacy services that pay for themselves.药物利用与治疗干预项目:能实现自给自足的药学服务。
Can J Hosp Pharm. 1994 Oct;47(5):203-8.
2
ASHP national survey of hospital-based pharmaceutical services--1992.美国卫生系统药师协会医院药学服务全国性调查——1992年
Am J Hosp Pharm. 1993 Jul;50(7):1371-404.
3
ASHP national survey of hospital-based pharmaceutical services--1990.美国卫生系统药师协会1990年医院药学服务全国调查
Am J Hosp Pharm. 1990 Dec;47(12):2665-95.
4
Focus and impact of pharmacists' interventions.药剂师干预措施的重点与影响。
Can J Hosp Pharm. 1993 Jun;46(3):101-8.
5
Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.临床药师对重症监护病房药物治疗中成本节约和成本规避的影响。
Hosp Pharm. 1994 Mar;29(3):215-8, 221.
6
Impact of a target drug monitoring program on the usage of clindamycin.
Can J Hosp Pharm. 1994 Apr;47(2):53-8.
7
Patient care contributions of clinical pharmacists in four ambulatory care clinics.临床药剂师在四家门诊护理诊所对患者护理的贡献。
Hosp Pharm. 1992 Mar;27(3):203-6, 208-9.
8
Four years' experience with a clinical intervention program: cost avoidance and impact of a clinical coordinator.一项临床干预项目的四年经验:成本规避及临床协调员的影响
Am J Hosp Pharm. 1990 Dec;47(12):2701-5.
9
How pharmaceutical controls worked in one Ontario hospital.安大略省一家医院的药品管控是如何运作的。
Can J Hosp Pharm. 1994 Aug;47(4):176-9.
10
A vancomycin drug use evaluation and economic analysis in a cancer treatment centre.某癌症治疗中心的万古霉素药物使用评估与经济分析
Can J Hosp Pharm. 1994 Apr;47(2):59-64.